Pharma

Jan 8 2018

The Fortune 500 s fastest-growing pharmaceutical companies #pharmaceutical #machinery

#pharmaceutical industry growth # These are the Fortune 500’s fastest-growing pharma companies The pharmaceutical industry has been rocked in recent years by a confluence of patent expirations of blockbuster drugs, increasing competition from generics and new governmental and industry efforts to control costs the world over. That s made growth prospects for many pharma companies a risky and uncertain proposition. Some have pursued growth via innovative (and expensive) new drugs, like Gilead Science s hepatitis C treatment, Sovaldi, which can cost $84,000 for a full course. Some (see: Actavis) have pursued an aggressive acquisition strategy, buying their way to growth …

Nov 6 2017

Top 11 Fastest-Growing Generics Companies #pharmaceutical #rep #jobs

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …

Sep 8 2017

Top 11 Fastest-Growing Generics Companies #rusan #pharma

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …

Jun 14 2017

The Fortune 500 s fastest-growing pharmaceutical companies #idis #pharma

#pharmaceutical industry growth # These are the Fortune 500’s fastest-growing pharma companies The pharmaceutical industry has been rocked in recent years by a confluence of patent expirations of blockbuster drugs, increasing competition from generics and new governmental and industry efforts to control costs the world over. That s made growth prospects for many pharma companies a risky and uncertain proposition. Some have pursued growth via innovative (and expensive) new drugs, like Gilead Science s hepatitis C treatment, Sovaldi, which can cost $84,000 for a full course. Some (see: Actavis) have pursued an aggressive acquisition strategy, buying their way to growth …

May 31 2017

Top 11 Fastest-Growing Generics Companies #world-pharma.org

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …

May 30 2017

The Fortune 500 s fastest-growing pharmaceutical companies #catalent #pharma #solutions

#pharmaceutical industry growth # These are the Fortune 500’s fastest-growing pharma companies The pharmaceutical industry has been rocked in recent years by a confluence of patent expirations of blockbuster drugs, increasing competition from generics and new governmental and industry efforts to control costs the world over. That s made growth prospects for many pharma companies a risky and uncertain proposition. Some have pursued growth via innovative (and expensive) new drugs, like Gilead Science s hepatitis C treatment, Sovaldi, which can cost $84,000 for a full course. Some (see: Actavis) have pursued an aggressive acquisition strategy, buying their way to growth …

Apr 30 2017

Top 11 Fastest-Growing Generics Companies #chicago #pharmaceutical #companies

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …

Apr 21 2017

Top 11 Fastest-Growing Generics Companies #northern #pharma

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …

Apr 20 2017

The Fortune 500 s fastest-growing pharmaceutical companies #history #of #pharmaceutical #industry

#pharmaceutical industry growth # These are the Fortune 500’s fastest-growing pharma companies The pharmaceutical industry has been rocked in recent years by a confluence of patent expirations of blockbuster drugs, increasing competition from generics and new governmental and industry efforts to control costs the world over. That s made growth prospects for many pharma companies a risky and uncertain proposition. Some have pursued growth via innovative (and expensive) new drugs, like Gilead Science s hepatitis C treatment, Sovaldi, which can cost $84,000 for a full course. Some (see: Actavis) have pursued an aggressive acquisition strategy, buying their way to growth …

Mar 19 2017

The Fortune 500 s fastest-growing pharmaceutical companies #aristo #pharma

#pharmaceutical industry growth # These are the Fortune 500’s fastest-growing pharma companies The pharmaceutical industry has been rocked in recent years by a confluence of patent expirations of blockbuster drugs, increasing competition from generics and new governmental and industry efforts to control costs the world over. That s made growth prospects for many pharma companies a risky and uncertain proposition. Some have pursued growth via innovative (and expensive) new drugs, like Gilead Science s hepatitis C treatment, Sovaldi, which can cost $84,000 for a full course. Some (see: Actavis) have pursued an aggressive acquisition strategy, buying their way to growth …